Key result
This review highlights recent advances in understanding the mechanisms of diabetic cardiomyopathy, including insulin resistance, microRNA dysregulation, and reactive oxygen species.
This review highlights recent advances in understanding the mechanisms of diabetic cardiomyopathy, including insulin resistance, microRNA dysregulation, and reactive oxygen species.
Advances in diabetic cardiomyopathy mechanisms extend understanding; leaves open targeted therapies pending clinical validation.
The proposal that diabetes plays a role in the development of heart failure is supported by the increased risk associated with this disease, even after correcting for all other known risk factors. However, the precise mechanisms contributing to the condition referred to as diabetic cardiomyopathy have remained elusive, as does defining the disease itself. Decades of study have defined numerous potential factors that each contribute to disease susceptibility, progression, and severity. Many recent detailed reviews have been published on mechanisms involving insulin resistance, dysregulation of microRNAs, and increased reactive oxygen species, as well as causes including both modifiable and non-modifiable risk factors. As such, the focus of the current review is to highlight aspects of each of these topics and to provide specific examples of recent advances in each area.
No takes yet. Share an insight, caveat, or question.
Williams et al. (2017) conducted a review in Diabetic cardiomyopathy. Diabetes was evaluated. This review highlights recent advances in understanding the mechanisms of diabetic cardiomyopathy, including insulin resistance, microRNA dysregulation, and reactive oxygen species.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: